Daily Market Reports | May 13 2026
This story features AUCKLAND INTERNATIONAL AIRPORT LIMITED, and other companies.
For more info SHARE ANALYSIS: AIA
The company is included in ASX200, ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
AIA ALQ ASG ATA BTL CSL (2) D3E DUG FCL HPG ING IOD KYP M7T MTS NWS PEB PME RDY SHA
AIA AUCKLAND INTERNATIONAL AIRPORT LIMITED
Infrastructure & Utilities – Overnight Price: $6.88
Jarden rates ((AIA)) as Neutral (3) –
Jarden maintains a Neutral rating for Auckland International Airport and reduces the target price to NZ$7.94 from NZ$7.97 following further airline capacity cuts in response to elevated jet fuel costs.
Currently scheduled international seat capacity for the second half of FY26 has declined by -4.4%, while domestic capacity has fallen -3.9% compared to pre-conflict levels.
Passenger volumes are holding up well with load factors lifting materially, positioning the business to comfortably achieve FY26 underlying profit guidance, according to the report.
The aeronautical price path has been updated to push price increases back to align with the deferred 2029 commissioning of the domestic jet terminal, resulting in roughly -NZ$800m of revenue being shifted into later regulatory periods.
Normalised earnings per share forecasts have been revised to NZ17.23c in FY26, NZ20.70c in FY27, and NZ25.45c in FY28.
This report was published on May 11, 2026.
Current Price is $6.88. Target price not assessed.
Current consensus price target is $7.26, suggesting upside of 5.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 11.82 cents and EPS of 15.09 cents.
At the last closing share price the estimated dividend yield is 1.72%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 45.60.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.1, implying annual growth of N/A.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 45.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 12.70 cents and EPS of 18.13 cents.
At the last closing share price the estimated dividend yield is 1.85%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 37.95.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.8, implying annual growth of 4.6%.
Current consensus DPS estimate is 11.4, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 43.5.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ALQ ALS LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $21.34
Jarden rates ((ALQ)) as Underweight (4) –
Jarden maintains an Underweight rating for ALS Ltd and lowers the target price to $18.10 from $18.40 ahead of the impending full-year earnings release.
The report notes the upcoming result will focus heavily on the Commodities division, where underlying earnings growth is expected to accelerate relative to the first half.
The broker anticipates the Life Sciences division will also show improvement, supported by a return to growth for Nuvisan and a potential turnaround for York.
Looking toward FY27, management’s outlook may face scrutiny regarding margin sustainability and potential negative impacts from foreign exchange translation, according to the report.
Earnings per share forecasts stand at 74.2c in FY26, 86.6c in FY27, and 95.8c in FY28.
This report was published on May 11, 2026.
Target price is $18.10 Current Price is $21.34 Difference: minus $3.24 (current price is over target).
If ALQ meets the Jarden target it will return approximately minus 15% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $25.70, suggesting upside of 20.4%(ex-dividends)
The company’s fiscal year ends in March.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 74.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.76.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 73.3, implying annual growth of 38.5%.
Current consensus DPS estimate is 42.3, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 29.1.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 86.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 87.0, implying annual growth of 18.7%.
Current consensus DPS estimate is 49.9, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 24.5.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASG AUTOSPORTS GROUP LIMITED
Automobiles & Components – Overnight Price: $2.36
Moelis rates ((ASG)) as Buy (1) –
Moelis maintains a Buy rating for Autosports Group with a $3.43 target price following an update on trading conditions.
Robust demand for battery electric vehicles is driving a record order bank, although the broker notes near-term earnings face margin compression as elevated staffing costs precede a surge in vehicle deliveries expected during FY27.
A rapid transition toward electric models has created excess supply for internal combustion engine vehicles, potentially weighing on margins through discounting, alongside broader macroeconomic headwinds and higher interest costs.
Despite these challenges, the report suggests the company’s luxury market demographic provides insulation from cost-of-living pressures, positioning the business to capture long-term growth and pursue further strategic acquisitions.
Reflecting recent dilution from the Solitaire Group acquisition and rising costs, earnings per share forecasts have been downgraded by -5% to -9%, establishing estimates of 24.6c in FY26, 29.2c in FY27, and 35.1c in FY28.
This report was published on May 12, 2026.
Target price is $3.43 Current Price is $2.36 Difference: $1.07
If ASG meets the Moelis target it will return approximately 45% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 9.70 cents and EPS of 24.60 cents.
At the last closing share price the estimated dividend yield is 4.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.59.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 11.40 cents and EPS of 29.20 cents.
At the last closing share price the estimated dividend yield is 4.83%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.08.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ATA ATTURRA LIMITED
Software & Services – Overnight Price: $0.46
Shaw and Partners rates ((ATA)) as Buy (1) –
Shaw and Partners maintains a Buy rating for Atturra with an unchanged $1.15 target price following a confident update at the TechRise Conference.
Chief Executive Officer Stephen Kowal reaffirmed FY26 guidance, noting the business is returning to growth in the second half.
Commentary states accelerating demand across data, security, and artificial intelligence-readiness consulting is offsetting weakness in other divisions, underpinning confidence heading into FY27 and FY28.
Margins are expected to benefit from recent restructuring initiatives and automation-led efficiencies within managed services, alongside improving cross-selling traction and stronger momentum across proprietary software products.
The current valuation appears highly undemanding to the broker, with the stock trading on an FY27 enterprise value-to-cash earnings multiple of just 4.4x compared to the 12.0x multiple implied by the target price.
This report was published on May 12, 2026.
Target price is $1.15 Current Price is $0.46 Difference: $0.69
If ATA meets the Shaw and Partners target it will return approximately 150% (excluding dividends, fees and charges).
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.14.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.79.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BTL BEETALOO ENERGY AUSTRALIA LIMITED
Energy – Overnight Price: $0.31
Research as a Service (RaaS) rates ((BTL)) as No Rating (-1) –
Beetaloo Energy Australia had a quiet March quarter although confirmation of a return to field activity, with mobilisation of the first gas plant modules and imminent resumption of well testing, indicates to Research as a Service (RaaS) that the next six months to first gas production can continue to unwind project risks.
Should drilling campaigns deliver to expectations, then LNG scale gas resources can be firmed as realistic development options, with material prospective upside for the company. RaaS has a midpoint valuation of $0.94.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on May 8, 2026.
Target price is $0.94 Current Price is $0.31 Difference: $0.63
If BTL meets the Research as a Service (RaaS) target it will return approximately 203% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $98.55
Canaccord Genuity rates ((CSL)) as Downgrade to Hold from Buy (3) –
Canaccord Genuity downgrades CSL to a Hold rating from Buy with a $106.31 target price following a significant downgrade to FY26 guidance.
The broker notes lower earnings expectations reflect a structural reset in immunoglobulin and albumin sales, which is offsetting ongoing volume growth.
The update includes a substantial impairment charge related to Vifor Pharmaceuticals alongside reductions in research and development spending.
Future valuation remains pressured by competitive erosion and the loss of FDA approval for Tavneos, with forecasts revised lower across the outer years, according to the report.
This report was published on May 12, 2026.
Target price is $106.31 Current Price is $98.55 Difference: $7.76
If CSL meets the Canaccord Genuity target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $134.94, suggesting upside of 36.9%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 880.3, implying annual growth of N/A.
Current consensus DPS estimate is 399.3, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 11.2.
Forecast for FY27:
Current consensus EPS estimate is 913.2, implying annual growth of 3.7%.
Current consensus DPS estimate is 416.5, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 10.8.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Jarden rates ((CSL)) as Downgrade to Neutral from Overweight (3) –
Jarden downgrades CSL to a Neutral rating from Overweight and lowers its target price to $191.00 from $244.00 following an unexpected severe downgrade to FY26 profit guidance.
Management reduced constant currency net profit expectations to roughly US$3.1bn, reflecting “unrealistic” prior ambitions for key products including Ig and Albumin, the broker comments.
Misjudged pricing across the product suite is seen impacting both revenue and gross margins, setting up a multi-year turnaround story as competition increases and reimbursement cuts persist, according to the report.
While underlying value remains within the business, near-term catalysts for upside are viewed by the broker as notably absent.
Net profit forecasts have been cut by -8.9%, -16.0%, and -20.8% across the next three years, establishing earnings per share estimates of US580.2c in FY26, US584.6c in FY27, and US610.9c in FY28.
This report was published on May 12, 2026.
Target price is $191.00 Current Price is $98.55 Difference: $92.45
If CSL meets the Jarden target it will return approximately 94% (excluding dividends, fees and charges).
Current consensus price target is $134.94, suggesting upside of 36.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 864.94 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.39.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 880.3, implying annual growth of N/A.
Current consensus DPS estimate is 399.3, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 11.2.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 871.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.31.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 913.2, implying annual growth of 3.7%.
Current consensus DPS estimate is 416.5, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 10.8.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
D3E D3 ENERGY LIMITED
NatGas – Overnight Price: $0.40
Research as a Service (RaaS) rates ((D3E)) as No Rating (-1) –
Research as a Service (RaaS) assesses D3 Energy continues to represent a compelling investment case, increasingly so given the current energy supply crisis.
The association of natural gas with helium concentrations provides a means to differentiate the company from its listed upstream peers.
As the company continues to work through its applications to achieve commercial resolution and reach FID by the end of 2026, corporate interest, either through merger or partnering activity, is not unrealistic in the analyst’s view.
Given the dilution after a successful capital raising, the valuation range is reset to $1.31-$2.54 per share, with a midpoint of $2.05.
Research as a Service (RaaS) research standard doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on May 6, 2026.
Target price is $2.05 Current Price is $0.40 Difference: $1.655
If D3E meets the Research as a Service (RaaS) target it will return approximately 419% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.74 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 22.70.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 1.56 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 25.32.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
DUG DUG TECHNOLOGY LIMITED
Cloud services – Overnight Price: $2.33
Shaw and Partners rates ((DUG)) as Buy (1) –
Shaw and Partners maintains a Buy rating for Dug Technology with a $3.00 price target following a presentation at the TechRise Conference.
Management reaffirmed FY26 trading is on track, supported by growing demand for software and high-performance computing services.
The broker notes strong momentum in Brazil and a recent Petronas contract are validating the company’s technology positioning against larger industry peers.
Future valuation is supported by expanding recurring revenue opportunities and expected margin improvement as the business increasingly competes on differentiated capability rather than pricing, according to the report.
This report was published on May 12, 2026.
Target price is $3.00 Current Price is $2.33 Difference: $0.67
If DUG meets the Shaw and Partners target it will return approximately 29% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 46.60.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 9.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.33.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FCL FINEOS CORPORATION HOLDINGS PLC
Cloud services – Overnight Price: $2.72
Moelis rates ((FCL)) as Buy (1) –
Moelis maintains a Buy rating for Fineos Corp with a $3.18 target price following a solid first quarter cash flow result.
Revenue estimates have been increased to EUR149m to align with management guidance as foreign exchange headwinds begin to dissipate.
The broker notes the strategic focus on subscription-based sales is successfully driving structural margin and cash flow expansion.
IT system renewals are expected to become a strategic priority for insurers seeking to capture artificial intelligence enabled productivity gains.
Earnings per share forecasts have been revised to 1.6c in FY26, 2.0c in FY27, and 4.3c in FY28.
This report was published on May 12, 2026.
Target price is $3.18 Current Price is $2.72 Difference: $0.46
If FCL meets the Moelis target it will return approximately 17% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Moelis forecasts a full year FY26 EPS of 2.78 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 97.91.
Forecast for FY27:
Moelis forecasts a full year FY27 EPS of 3.47 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 78.34.
This company reports in EUR. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HPG HIPAGES GROUP HOLDINGS LIMITED
Online media & mobile platforms – Overnight Price: $0.74
Shaw and Partners rates ((HPG)) as Buy (1) –
Shaw and Partners maintains a Buy rating for hipages Group with an unchanged $2.50 target price following a confident update at the TechRise Conference.
Founder and Chief Executive Officer Roby Sharon-Zipser reiterated FY26 guidance, highlighting softer subscriber volumes are being offset by strong yield trends operating at record levels.
The broker notes management expects a robust start to FY27, supported by an impending subscription price increase linked to the rollout of new artificial intelligence-enabled products.
Disciplined cost controls and growing job management adoption are anticipated to drive structurally higher customer retention, monetisation, and margins.
According to the report, the business remains well-positioned to leverage proprietary data and trusted marketplace infrastructure to establish artificial intelligence as a distinct competitive advantage.
This report was published on May 12, 2026.
Target price is $2.50 Current Price is $0.74 Difference: $1.76
If HPG meets the Shaw and Partners target it will return approximately 238% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.44.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 3.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.00.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ING INGHAMS GROUP LIMITED
Food, Beverages & Tobacco – Overnight Price: $1.96
Jarden rates ((ING)) as Upgrade to Overweight from Neutral (2) –
Jarden upgrades Inghams Group to an Overweight rating from Neutral and raises the $2.70 target price from $2.50 following a positive strategy day.
The report highlights increased forecasts driven by improving 2HYTD trading and contract wins, despite a temporary headwind from Middle East fuel costs.
Management reaffirmed FY26 EBIT guidance of $180m to $200m and identified $130m in gross productivity opportunities through FY31, the broker reports.
Earnings per share forecasts have been revised upward to 12.3c from 12.1c for FY26 and to 18.7c from 18.0c for FY27.
Dividend estimates for the same periods are projected at 8.7c and 13.2c.
This report was published on May 11, 2026.
Target price is $2.70 Current Price is $1.96 Difference: $0.745
If ING meets the Jarden target it will return approximately 38% (excluding dividends, fees and charges).
Current consensus price target is $2.38, suggesting upside of 21.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 8.70 cents and EPS of 12.30 cents.
At the last closing share price the estimated dividend yield is 4.45%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.89.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.9, implying annual growth of -30.0%.
Current consensus DPS estimate is 10.7, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 11.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 13.20 cents and EPS of 18.70 cents.
At the last closing share price the estimated dividend yield is 6.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.45.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 22.9, implying annual growth of 35.5%.
Current consensus DPS estimate is 14.5, implying a prospective dividend yield of 7.4%.
Current consensus EPS estimate suggests the PER is 8.6.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IOD IODM LIMITED
Cloud services – Overnight Price: $0.17
Shaw and Partners rates ((IOD)) as Buy (1) –
Shaw and Partners maintains a Buy rating for IODM with an unchanged $0.29 target price following a confident update at the TechRise Conference.
Chief Executive Officer Mark Reilly noted the next strategic phase will focus on converting the North American partner-led pipeline into scalable growth, with early Tier 1 university engagement supporting confidence, according to the report.
Management indicated artificial intelligence-enabled self-service onboarding is reducing operational bottlenecks, allowing the business to lower implementation friction ahead of an accelerated US rollout.
The broker highlights revenue-share economics are expected to improve rather than compress as the platform scales, while stronger conversion momentum could potentially bring forward the path to cash-flow breakeven.
Underlying earnings per share forecasts stand at -0.3c in FY26, -0.0c in FY27, and 0.3c in FY28.
This report was published on May 12, 2026.
Target price is $0.29 Current Price is $0.17 Difference: $0.115
If IOD meets the Shaw and Partners target it will return approximately 66% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 58.33.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
KYP KINATICO LIMITED
Software & Services – Overnight Price: $0.16
Shaw and Partners rates ((KYP)) as Buy (1) –
Shaw and Partners maintains a Buy rating for Kinatico with a $0.38 target price following an update at the TechRise Conference.
Chief Executive Officer Michael Ivanchenko highlighted the compliance data pipeline has expanded beyond the previously disclosed $12m, with conversions nearing an inflection point, according to the report.
Management pushed back on broader software-as-a-service concerns, noting artificial intelligence serves as a structural benefit underpinned by the firm’s trusted compliance data and native architecture.
The broker highlights significant operating leverage potential within the platform, as management stated the business could potentially double revenue without requiring any change to operating headcount.
Underlying earnings per share forecasts stand at 0.5c in FY26, 1.1c in FY27, and 1.9c in FY28.
This report was published on May 12, 2026.
Target price is $0.38 Current Price is $0.16 Difference: $0.22
If KYP meets the Shaw and Partners target it will return approximately 138% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.00.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.55.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
M7T MACH7 TECHNOLOGIES LIMITED
Healthcare services – Overnight Price: $0.27
Canaccord Genuity rates ((M7T)) as Downgrade to Hold from Buy (3) –
Canaccord Genuity downgrades Mach7 Technologies to a Hold rating from Buy and lowers the target price to $0.27 from $0.80.
The broker notes the company has entered a strategic reset following recent management transitions, with visibility into the path toward cash flow breakeven remaining limited.
Revenue forecasts have been revised down by -23% to -28% for FY26-FY28 to reflect delayed conversion of large capital deals and a headwind from AUD:USD exchange rate movements.
Operating cash flow is projected to remain a negative outflow until FY29, while cost-reduction measures implemented by the new leadership may exacerbate challenges in sales execution and service delivery.
Normalised EBITDA estimates have been materially impaired due to a weaker revenue mix and a flat near-term growth trajectory, according to the report.
This report was published on May 12, 2026.
Target price is $0.27 Current Price is $0.27 Difference: $0
If M7T meets the Canaccord Genuity target it will return approximately 0% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MTS METCASH LIMITED
Food, Beverages & Tobacco – Overnight Price: $2.94
Jarden rates ((MTS)) as Overweight (2) –
Jarden maintains an Overweight rating for Metcash and raises the target price to $3.90 from $3.80 following the pre-release of the upcoming FY26 financial results.
The underlying update proved better than feared by the broker, with stronger top-line trends across hardware and liquor helping to offset heightened competitive intensity.
A margin contraction of -70 basis points within the hardware division is anticipated during the second half, alongside a loss of food market share to major competitors.
Despite these pressures, the report notes management executed the period well, supported by strong cash flow generation and the announcement of further cost-out initiatives.
Earnings per share forecasts have been adjusted to reflect the result alongside tempered mid-cycle margin expectations, establishing estimates of 24.4c in FY26, 26.6c in FY27, and 28.0c in FY28.
This report was published on May 11, 2026.
Target price is $3.90 Current Price is $2.94 Difference: $0.96
If MTS meets the Jarden target it will return approximately 33% (excluding dividends, fees and charges).
Current consensus price target is $3.26, suggesting upside of 10.9%(ex-dividends)
The company’s fiscal year ends in April.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 24.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 24.0, implying annual growth of -7.2%.
Current consensus DPS estimate is 17.8, implying a prospective dividend yield of 6.1%.
Current consensus EPS estimate suggests the PER is 12.3.
Forecast for FY27:
Jarden forecasts a full year FY27 EPS of 26.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.7, implying annual growth of 7.1%.
Current consensus DPS estimate is 18.2, implying a prospective dividend yield of 6.2%.
Current consensus EPS estimate suggests the PER is 11.4.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NWS NEWS CORPORATION
Print, Radio & TV – Overnight Price: $43.08
Jarden rates ((NWS)) as Overweight (2) –
Jarden rates News Corp Overweight with an unchanged $46.30 target price following a solid third-quarter result beating market expectations on the back of strong Dow Jones performance.
Group revenue grew 8.8% to US$2,185m and underlying earnings jumped 18% to US$343m, driven by robust momentum across the Professional Information Services division and higher physical and digital book sales.
A softer News Media segment weighed slightly on the result due to costs associated with the California Post launch.
Management continues executing an accelerated share buyback program while progressing discussions with artificial intelligence companies to monetise proprietary data.
The report leaves valuation metrics steady, highlighting potential upside from further tech partnerships and a broader recovery in digital real estate volumes.
This report was published on May 8, 2026.
Target price is $46.30 Current Price is $43.08 Difference: $3.22
If NWS meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $52.13, suggesting upside of 21.0%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 145.3, implying annual growth of N/A.
Current consensus DPS estimate is 27.6, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 29.6.
Forecast for FY27:
Current consensus EPS estimate is 181.2, implying annual growth of 24.7%.
Current consensus DPS estimate is 27.6, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 23.8.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PEB PACIFIC EDGE LIMITED
Medical Equipment & Devices – Overnight Price: $0.14
Jarden rates ((PEB)) as Initiation of coverage with Neutral (3) –
Jarden maintains a Neutral rating on Pacific Edge, with an unchanged NZ$0.160 target price following the launch of an NZ$24m equity raising.
The broker expects the capital raising to extend the company’s funding runway while management awaits a key Medicare coverage decision expected before September 2026.
Recent operating performance remained weak, reflecting ongoing pressure in the US business, according to the report.
Future valuation remains tied to securing Medicare re-coverage, with additional funding likely required to support broader commercial expansion.
This report was published on May 11, 2026.
Current Price is $0.14. Target price not assessed.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PME PRO MEDICUS LIMITED
Medical Equipment & Devices – Overnight Price: $125.93
Canaccord Genuity rates ((PME)) as Buy (1) –
Canaccord Genuity maintains a Buy rating for Pro Medicus and reduces the target price to $168.62 from $180.82 following a review of the company’s valuation relative to sector-wide multiple compression.
Revenue forecasts have been revised down by -8% for FY26 and -11% for FY27 to reflect lower data migration revenue and a higher AUD:USD exchange rate headwind.
The broker notes underlying fundamentals remain exceptional, with the business expected to deliver growth exceeding 20% on both the top and bottom lines despite negative sector sentiment.
Large contract wins yet to materialise in the profit and loss statement underpin significant earnings momentum for FY27 and FY28.
Mispricing is evident as market volatility masks the value of businesses with high excess cash returns, according to the report.
This report was published on May 12, 2026.
Target price is $168.62 Current Price is $125.93 Difference: $42.69
If PME meets the Canaccord Genuity target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $224.17, suggesting upside of 78.0%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 182.2, implying annual growth of 65.2%.
Current consensus DPS estimate is 67.2, implying a prospective dividend yield of 0.5%.
Current consensus EPS estimate suggests the PER is 69.1.
Forecast for FY27:
Current consensus EPS estimate is 194.4, implying annual growth of 6.7%.
Current consensus DPS estimate is 86.3, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 64.8.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
RDY READYTECH HOLDINGS LIMITED
Software & Services – Overnight Price: $1.35
Shaw and Partners rates ((RDY)) as Buy (1) –
Shaw and Partners maintains a Buy rating for ReadyTech Holdings with an unchanged $2.80 target price following an update at the TechRise Conference.
Management reiterated FY26 guidance, noting earlier churn pressures are stabilising and second-half pipeline conversions are improving.
Commentary suggests a shifting focus toward recurring subscription revenue over lumpy implementation services provides a clearer narrative for future cash flow stability, while margins are expected to have bottomed out.
The broker highlights artificial intelligence-driven engineering productivity is increasingly viewed as a medium-term catalyst capable of structurally improving the cost base, supported by a more disciplined approach to portfolio rationalisation.
Earnings per share estimates remain unchanged at 0.7c in FY26, 2.8c in FY27, and 13.9c in FY28.
This report was published on May 12, 2026.
Target price is $2.80 Current Price is $1.35 Difference: $1.445
If RDY meets the Shaw and Partners target it will return approximately 107% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 193.57.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 48.39.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SHA SHAPE AUSTRALIA CORPORATION LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $7.69
Moelis rates ((SHA)) as Buy (1) –
Moelis maintains a Buy rating for Shape Australia and increases the target price to $8.33 following a strong FY26 trading update.
Record project wins of $1.16bn and healthy backlog levels underpin maiden FY26 revenue guidance ranging from $1.175bn to $1.225bn.
Execution on growth strategies has shifted the business mix toward higher-value modular work and non-commercial end markets including data centres and aged care, according to the report.
The broker notes modular revenue more than doubled FY25 levels, while data centre contributions grew to 10% of total revenue.
Earnings per share estimates have been upgraded by roughly 1% across FY26-FY28 to reflect strong activity levels and justified valuation multiples.
This report was published on May 12, 2026.
Target price is $8.33 Current Price is $7.69 Difference: $0.64
If SHA meets the Moelis target it will return approximately 8% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 31.00 cents and EPS of 35.90 cents.
At the last closing share price the estimated dividend yield is 4.03%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.42.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 34.70 cents and EPS of 40.20 cents.
At the last closing share price the estimated dividend yield is 4.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.13.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: AIA - AUCKLAND INTERNATIONAL AIRPORT LIMITED
For more info SHARE ANALYSIS: ALQ - ALS LIMITED
For more info SHARE ANALYSIS: ASG - AUTOSPORTS GROUP LIMITED
For more info SHARE ANALYSIS: ATA - ATTURRA LIMITED
For more info SHARE ANALYSIS: BTL - BEETALOO ENERGY AUSTRALIA LIMITED
For more info SHARE ANALYSIS: CSL - CSL LIMITED
For more info SHARE ANALYSIS: D3E - D3 ENERGY LIMITED
For more info SHARE ANALYSIS: DUG - DUG TECHNOLOGY LIMITED
For more info SHARE ANALYSIS: FCL - FINEOS CORPORATION HOLDINGS PLC
For more info SHARE ANALYSIS: HPG - HIPAGES GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: ING - INGHAMS GROUP LIMITED
For more info SHARE ANALYSIS: IOD - IODM LIMITED
For more info SHARE ANALYSIS: KYP - KINATICO LIMITED
For more info SHARE ANALYSIS: M7T - MACH7 TECHNOLOGIES LIMITED
For more info SHARE ANALYSIS: MTS - METCASH LIMITED
For more info SHARE ANALYSIS: NWS - NEWS CORPORATION
For more info SHARE ANALYSIS: PEB - PACIFIC EDGE LIMITED
For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED
For more info SHARE ANALYSIS: RDY - READYTECH HOLDINGS LIMITED
For more info SHARE ANALYSIS: SHA - SHAPE AUSTRALIA CORPORATION LIMITED